1
|
Berastegui N, Ainciburu M, Romero JP, Garcia-Olloqui P, Alfonso-Pierola A, Philippe C, Vilas-Zornoza A, San Martin-Uriz P, Ruiz-Hernández R, Abarrategi A, Ordoñez R, Alignani D, Sarvide S, Castro-Labrador L, Lamo-Espinosa JM, San-Julian M, Jimenez T, López-Cadenas F, Muntion S, Sanchez-Guijo F, Molero A, Montoro MJ, Tazón B, Serrano G, Diaz-Mazkiaran A, Hernaez M, Huerga S, Bewicke-Copley F, Rio-Machin A, Maurano MT, Díez-Campelo M, Valcarcel D, Rouault-Pierre K, Lara-Astiaso D, Ezponda T, Prosper F. The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes. Nat Commun 2022; 13:7619. [PMID: 36494342 PMCID: PMC9734135 DOI: 10.1038/s41467-022-35192-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2021] [Accepted: 11/21/2022] [Indexed: 12/13/2022] Open
Abstract
Myelodysplastic syndromes (MDS) are hematopoietic stem cell (HSC) malignancies characterized by ineffective hematopoiesis, with increased incidence in older individuals. Here we analyze the transcriptome of human HSCs purified from young and older healthy adults, as well as MDS patients, identifying transcriptional alterations following different patterns of expression. While aging-associated lesions seem to predispose HSCs to myeloid transformation, disease-specific alterations may trigger MDS development. Among MDS-specific lesions, we detect the upregulation of the transcription factor DNA Damage Inducible Transcript 3 (DDIT3). Overexpression of DDIT3 in human healthy HSCs induces an MDS-like transcriptional state, and dyserythropoiesis, an effect associated with a failure in the activation of transcriptional programs required for normal erythroid differentiation. Moreover, DDIT3 knockdown in CD34+ cells from MDS patients with anemia is able to restore erythropoiesis. These results identify DDIT3 as a driver of dyserythropoiesis, and a potential therapeutic target to restore the inefficient erythroid differentiation characterizing MDS patients.
Collapse
Affiliation(s)
- Nerea Berastegui
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain ,grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
| | - Marina Ainciburu
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain ,grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
| | - Juan P. Romero
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain ,grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
| | - Paula Garcia-Olloqui
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain ,grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
| | - Ana Alfonso-Pierola
- grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain ,grid.411730.00000 0001 2191 685XDepartment of Hematology, Clínica Universidad de Navarra, Universidad de Navarra and CCUN, 31008 Pamplona, Spain
| | - Céline Philippe
- grid.4868.20000 0001 2171 1133Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, England UK
| | - Amaia Vilas-Zornoza
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain ,grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
| | - Patxi San Martin-Uriz
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain
| | - Raquel Ruiz-Hernández
- Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), San Sebastian, Spain
| | - Ander Abarrategi
- Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), San Sebastian, Spain ,grid.424810.b0000 0004 0467 2314Ikerbasque, Basque Foundation for Science, Bilbao, Spain
| | - Raquel Ordoñez
- grid.137628.90000 0004 1936 8753Institute for Systems Genetics, NYU School of Medicine, New York, NY USA
| | - Diego Alignani
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain ,grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
| | - Sarai Sarvide
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain ,grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
| | - Laura Castro-Labrador
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain ,grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
| | - José M. Lamo-Espinosa
- grid.411730.00000 0001 2191 685XDepartment of Orthopedic Surgery and Traumatology, Clínica Universidad de Navarra, Universidad de Navarra and CCUN, 31008 Pamplona, Spain
| | - Mikel San-Julian
- grid.411730.00000 0001 2191 685XDepartment of Orthopedic Surgery and Traumatology, Clínica Universidad de Navarra, Universidad de Navarra and CCUN, 31008 Pamplona, Spain
| | - Tamara Jimenez
- grid.11762.330000 0001 2180 1817Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Universidad de Salamanca, Salamanca, Spain
| | - Félix López-Cadenas
- grid.11762.330000 0001 2180 1817Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Universidad de Salamanca, Salamanca, Spain
| | - Sandra Muntion
- grid.11762.330000 0001 2180 1817Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Universidad de Salamanca, Salamanca, Spain
| | - Fermin Sanchez-Guijo
- grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain ,grid.11762.330000 0001 2180 1817Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Universidad de Salamanca, Salamanca, Spain
| | - Antonieta Molero
- grid.411083.f0000 0001 0675 8654Department of Hematology, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Barcelona, Spain
| | - Maria Julia Montoro
- grid.411083.f0000 0001 0675 8654Department of Hematology, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Barcelona, Spain
| | - Bárbara Tazón
- grid.411083.f0000 0001 0675 8654Department of Hematology, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Barcelona, Spain
| | - Guillermo Serrano
- grid.508840.10000 0004 7662 6114Computational Biology Program, Institute for data science and artificial intelligence (datai), CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Navarra, Spain
| | - Aintzane Diaz-Mazkiaran
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain ,grid.508840.10000 0004 7662 6114Computational Biology Program, Institute for data science and artificial intelligence (datai), CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Navarra, Spain
| | - Mikel Hernaez
- grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain ,grid.508840.10000 0004 7662 6114Computational Biology Program, Institute for data science and artificial intelligence (datai), CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Navarra, Spain
| | - Sofía Huerga
- grid.411730.00000 0001 2191 685XDepartment of Hematology, Clínica Universidad de Navarra, Universidad de Navarra and CCUN, 31008 Pamplona, Spain
| | - Findlay Bewicke-Copley
- grid.4868.20000 0001 2171 1133Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK
| | - Ana Rio-Machin
- grid.4868.20000 0001 2171 1133Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK
| | - Matthew T. Maurano
- grid.137628.90000 0004 1936 8753Institute for Systems Genetics, NYU School of Medicine, New York, NY USA ,grid.137628.90000 0004 1936 8753Department of Pathology, NYU School of Medicine, New York, NY USA
| | - María Díez-Campelo
- grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain ,grid.11762.330000 0001 2180 1817Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Universidad de Salamanca, Salamanca, Spain
| | - David Valcarcel
- grid.411083.f0000 0001 0675 8654Department of Hematology, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Barcelona, Spain
| | - Kevin Rouault-Pierre
- grid.4868.20000 0001 2171 1133Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, England UK
| | - David Lara-Astiaso
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain
| | - Teresa Ezponda
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain ,grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
| | - Felipe Prosper
- grid.508840.10000 0004 7662 6114Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain ,grid.413448.e0000 0000 9314 1427Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain ,grid.411730.00000 0001 2191 685XDepartment of Hematology, Clínica Universidad de Navarra, Universidad de Navarra and CCUN, 31008 Pamplona, Spain
| |
Collapse
|
8
|
Badenas C, Praga M, Tazón B, Heidet L, Arrondel C, Armengol A, Andrés A, Morales E, Camacho JA, Lens X, Dávila S, Milà M, Antignac C, Darnell A, Torra R. Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria. J Am Soc Nephrol 2002; 13:1248-1254. [PMID: 11961012 DOI: 10.1681/asn.v1351248] [Citation(s) in RCA: 90] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
Familial benign hematuria (FBH) is a common autosomal dominant disorder characterized by the presence of persistent or recurrent hematuria. The clinical and pathologic features of this syndrome resemble those of early Alport syndrome (AS), and for this reason a common molecular defect has been proposed. The COL4A3/4 genes seem to be involved in both autosomal AS and FBH. This study involves a linkage analysis for the COL4A3/4 loci and a search for mutations within these genes in 11 biopsy-proven FBH families. Haplotype analysis showed that linkage to the COL4A3/4 locus could not be excluded in eight of nine families. One family was not linked to this locus; however, it included three affected women who could be X-linked AS carriers. Two families were too small to perform linkage analysis. COL4A3 and COL4A4 mutation screening disclosed six new pathogenic mutations, two in the COL4A3 gene (G985V and G1015E) and four in the COL4A4 gene (3222insA, IVS23-1G>C, 31del11, and G960R). It is the first time that mutations within the COL4A3 gene are described in families with FBH. This study clearly demonstrates the main role of the COL4A4 and COL4A3 genes in the pathogenesis of FBH.
Collapse
Affiliation(s)
- Cèlia Badenas
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Manuel Praga
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Bárbara Tazón
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Laurence Heidet
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Christelle Arrondel
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Anna Armengol
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Amado Andrés
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Enrique Morales
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Juan Antonio Camacho
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Xose Lens
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Sonia Dávila
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Montse Milà
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Corinne Antignac
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Alejandro Darnell
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| | - Roser Torra
- *Nephrology and Genetics Departments, Hospital Clínic, Barcelona, Spain; Nephrology Department, Hospital 12 de Octubre, Madrid, Spain; Nephrology Department, Inserm U423, Université René Descartes, Hôpital Necker-Enfants Malades, Paris, France; Hospital Sant Joan de Déu, Barcelona, Spain; and #Nephrology Department, Hospital Clínico Universitario, Santiago de Compostela, Spain
| |
Collapse
|